Replies to post #384314 on NorthWest Biotherapeutics Inc (NWBO)

[jfr1611]

Agree 100% Redneck. There’s also more infos that I view very positive: the hiring of Kristine Power for the Canadian market, the up listing consultants, etc...

[HappyLibrarian]

Management has been transparent about the entire process.

No they have not.

As a wise man said “We are entitled to our own opinions but not our own facts.”

Transparency would include updating us on which stage of the process we are on, not giving very thin guidance in October 2020 and parroting the same things months later. Bear in mind they pulled that the article out of their bag of tricks after changing their previous guidance of TLD in September 2020 after they missed it and without being transparent as to the reason.

The fact that no one can agree where we are on in the process (which is a basic fact about the process being hidden from us) shows that they are not being transparent.

So you may defend their lack of transparency about the process (as many pro-management shareholders do) but you may not credibly say they are being transparent.

[exwannabe]

Management has been transparent about the entire process.

What was the cause of the FDA hold? <crickets chirping>
What happened with the 2015 efficacy IA? <crickets chirping>
Were the endpoints changed, to what, and what was the FDA response? <crickets chirping>
What has been the status post data lock? <crickets chirping>

Instead, they have made statements like expecting TLD in June/July 2020, then Aug, the Sep.

NWBO should have patented their playbook and they could sue CVM for infringement.